Who is the CEO of Nabla?

Alexandre Lebrun is the CEO of Nabla. The company was founded in 2018.

Where is Nabla located?

Nabla is headquartered in Paris, France (with U.S. operations).

What products does Nabla offer?

Nabla's key products include: Nabla Copilot.

What funding stage is Nabla at?

Nabla is currently at the Scaling stage.

How many employees does Nabla have?

Nabla has approximately N/A employees.

Nabla

Category: AI in Healthcare

An ambient AI assistant for healthcare practitioners that generates clinical notes from patient consultations to reduce administrative burden. Nabla was founded in 2018. The company is led by Alexandre Lebrun. Based in Paris, France (with U.S. operations). Team size: N/A. Total funding raised: $120M. Latest round: Series C. Key investors include HV Capital, Highland Europe, DST Global, Cathay Innovation, Build Collective, Radical Ventures.

Founded: 2018
Headquarters: Paris, France (with U.S. operations)
Team size: N/A
Total funding: $120M

Value proposition

To reduce clinician burnout and improve patient care by automating the generation of clinical documentation, allowing doctors to focus on patients rather than paperwork.

Products and solutions

Nabla Copilot

Unique value

Nabla was developed through a unique approach of co-creation with a community of thousands of clinicians. The company emphasizes its focus on improving clinicians' quality of life over purely revenue-cycle management and boasts high accuracy in creating concise notes that filter out non-medical conversation.

Target customer

Healthcare providers, including individual clinicians, physician groups, academic medical centers, and large health systems.

Industries served

Healthcare

Technology advantage

The founding team's deep expertise in AI from Meta's research division provides a strong technical foundation. The platform is designed for ease of use, requiring no special training, and integrates with major EHR systems like Epic and Nextgen. Its business advantage is demonstrated by rapid user adoption and large-scale partnerships.

How they differentiate

Nabla differentiates itself through its speed, accuracy, and user-centric design focused on reducing practitioner burnout. Unlike some competitors that prioritize revenue cycle management, Nabla's primary goal is to improve the clinical workflow and restore the joy of practicing medicine.

Main competitors

Suki, Abridge, Nuance (Microsoft)

Key partnerships

The Permanente Medical Group, Catalight, Neighborhood Healthcare, AstraZeneca, Bristol Myers Squibb, Takeda

Notable customers

The Permanente Medical Group, Catalight, Neighborhood Healthcare

Major milestones

Launch of Nabla Copilot in March 2023. Partnership with The Permanente Medical Group to roll out the tool to 10,000 doctors in October 2023. Raised $24M in Series B funding in January 2024. Raised $70M in Series C funding in June 2024.

Growth metrics

Deployed across more than 130 healthcare organizations, in use by 85,000 clinicians, processes millions of consultations per year.

Market positioning

Positioned as a leading and rapidly growing ambient AI assistant for healthcare, with significant traction in the U.S. and European markets.

Geographic focus

United States, Europe

Patents and IP

Not publicly disclosed.

About Alexandre Lebrun

Alexandre Lebrun is a seasoned entrepreneur and AI expert with a history of successful ventures. He co-founded and led Wit.ai, an AI company acquired by Facebook, where he then headed the Facebook AI Research (FAIR) team in Paris. Before that, he founded VirtuOz, a pioneer in chatbots. His latest venture, Nabla, leverages his deep experience in AI to tackle the challenges of the healthcare industry by creating an ambient AI assistant for clinicians.

Official website: https://www.nabla.com/